BioBoss

Mark Altmeyer, founder and CEO of Arvelle Therapeutics, speaks with BioBoss host John Simboli. Hear Mark’s thoughts about leadership and how Arvelle is working to bring new solutions to people living with epilepsy and CNS disorders.

Jacob Becraft, co-founder & CEO of Strand Therapeutics shares his thoughts with BioBoss host John Simboli about leadership and how Strand is working in synthetic biology and messenger RNA to target root causes of genetic disease, with the power to control editing at a single-cell level.

Eran Eden, co-founder and CEO of MeMed, shares his thoughts on leadership and how MeMed is working to translate signals from the immune system into diagnostic insights to treat infectious disease and inflammatory disorders. 

Nikolaj Sørensen, CEO of Orexo Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership and, digital and bio-therapeutics, how the coronavirus is changing the landscape around mental health, depression, substance abuse and addiction,

Per Hellsund, co-founder and CEO of Cybrexa Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership, building a culture of transparency, and Cybrexa's advances in treating the cancer tumor microenvironment.

CEO Clive Morris of Inivata, headquartered in Cambridge U.K., shares his thoughts with BioBoss host John Simboli about leadership in biotech and advances in non-invasive liquid biopsy to unlock genomic information and guide personalized cancer treatment.

Salubris Biotherapeutics Co-founder Samuel Murphy shares his thoughts about leadership in biopharma with BioBoss host John Simboli.  Samuel also discusses Salubris Biotherapeutics advances in therapeutics for the treatment of cancer, cardiovascular, and metabolic diseases. 

Gemini Therapeutics CEO Jason Meyenburg share his thoughts about leadership in biopharma with BioBoss host John Simboli.  Jason also discusses Gemini Therapeutics pioneering approach to developing precision medicines by leveraging genetics to work in diseases like dry AMD and linked diseases that have limited or no solutions.

I'm not afraid of the gray area or the darkness that surrounds a few inches in front of your face, which is really what this business is all about." - Constantine Theodorpulos, Founder and CEO of Go Therapeutics

"I really rely on the expertise of the team and I value input. I also value contradiction." - Ankit Mahadevia, founder and CEO of Spero Therapeutics